NISHIYAMA Hiroyuki
- Articles
- Durvalumab (D) in combination with Bacillus Calmette-Guerin (BCG) Induction (I) and Maintenance (M) therapy for BCG-naive, high-risk Non-Muscle-Invasive Bladder Cancer (NMIBC): Outcomes for Patients (pts) aged ≥65 years from POTOMAC
Palou J.; Nishiyama H.; Shore N.; Krawczynski M.; Sey...
EUROPEAN UROLOGY/89(1), 2026-03-01 - Prognostic impact of neoadjuvant chemotherapy for muscle-invasive bladder cancer in patients with low geriatric nutritional risk index: A retrospective cohort study
Omizo S.; Fujita N.; Kobayashi M.; Kandori S.; Ikaras...
EUROPEAN UROLOGY/89(1), 2026-03-01 - Current Treatment Patterns and Outcomes of Sex Cord Stromal Tumor Patients in Japan
Abe Takashige; Miyai Kosuke; Tsuzuki Toyonori; Murai ...
INTERNATIONAL JOURNAL OF UROLOGY/33(3), 2026-03 - This issue 31-2
Nishiyama Hiroyuki
International journal of urology : official journal of the Japanese Urological Association/31(2)/p.97, 2024-02-01 - Circulating tumor DNA (ctDNA) in patients with muscle-invasive bladder cancer (MIBC) who received perioperative durvalumab (D) in NIAGARA
Powles Thomas; Van Der Heijden Michiel Simon; Wang Yin...
JOURNAL OF CLINICAL ONCOLOGY/43(16_SUPPL:16_SUPPL)/pp.4503-4503, 2025-06-01 - Avelumab maintenance therapy in patients (pts) with advanced urothelial carcinoma (UC) in Japan: Subgroup analyses by best overall response (BOR) to prior platinum-based chemotherapy (PBC) in a post-marketing surveillance (PMS) population.
Kikuchi Eiji; Nagata Masayoshi; Ito Taito; Sato Masas...
JOURNAL OF CLINICAL ONCOLOGY/43(16_SUPPL:16_SUPPL)/pp.4561-4561, 2025-06-01 - Three-dimensional image reconstruction technology in laparoscopic pyeloplasty for horseshoe kidney-associated ureteropelvic junction obstruction: a case series study
Kandori Shuya; Kojo Kosuke; Hoshi Akio; Takahashi Reo...
BMC UROLOGY/26(1), 2025-12-27 - Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional Study
Shimizu Sayaka; Osawa Takahiro; Sato Miho; Yamada Shu...
International journal of urology : official journal of the Japanese Urological Association/33(2), 2026-02-01 - Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study
Kawahara Takashi; Nagumo Yoshiyuki; Yamaguchi Akane; H...
Cancer reports (Hoboken, N.J.)/9(1), 2026-01-01 - Active Surveillance Versus Intravesical Bacillus Calmette-Guérin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial
Kitamura Hiroshi; Tsukamoto Taiji; Kakehi Yoshiyuki; M...
European urology, 2026-01-21 - Bladder Preservation Therapy in Combination with Atezolizumab and Radiation Therapy (BPT-ART) for Invasive Bladder Cancer: Final Analysis from a Multicentre, Open-label, Prospective Phase 2 Trial
Nagumo Yoshiyuki; Kimura Tomokazu; Ishikawa Hitoshi; S...
European urology, 2026-01-17 - This Issue 32-12
Nishiyama Hiroyuki
International journal of urology : official journal of the Japanese Urological Association/32(12)/p.1723, 2025-12-01 - Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in Japan
Yamada Shuhei; Sato Miho; Osawa Takahiro; Harabayashi ...
CANCER SCIENCE, 2026-01-04 - Revealing intra-group immunotherapy response heterogeneity in metastatic urothelial carcinoma through interpretable feature extraction and spectral clustering
Nagumo Yoshiyuki; Ye Xiucai; Shi Tianyi; Mathis Bryan...
FRONTIERS IN IMMUNOLOGY/16, 2026-01-06 - Age-stratified outcomes of radical cystectomy for muscle-invasive bladder cancer: a nationwide multicenter study of 1867 patients in Japan
Kawai Taketo; Miki Jun; Taoka Rikiya; Saito Ryoichi; ...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY/56(4)/pp.475-483, 2026-01-16 - Incidence, risk factors, and clinical implications of enfortumab vedotinrelated cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in Japan
Kita Y.; Hara T.; Kawahara T.; Hashimoto K.; Matsushi...
ESMO REAL WORLD DATA AND DIGITAL ONCOLOGY/7, 2025-03 - Real-World Comparison of Survival Outcomes Between Radical Cystectomy and Intravesical Bacillus Calmette-Guérin (BCG) Therapy in BCG-Naïve or -Unresponsive Non-Muscle-Invasive Bladder Cancer
Miyake Makito; Nishimura Nobutaka; Taoka Rikiya; Miki ...
INTERNATIONAL JOURNAL OF UROLOGY, 2025-12-12 - Outcomes of sequential therapy for advanced upper tract urothelial cancer and bladder cancer
Kanesaka Manato; Sazuka Tomokazu; Kita Yuki; Fukuhara ...
SCIENTIFIC REPORTS/15(1), 2025-11-25 - Health-related quality of life (HRQoL) outcomes from the NIAGARA trial of perioperative durvalumab (D) plus neoadjuvant chemotherapy (NAC) in muscle-invasive bladder cancer (MIBC)
van der Heijden M. S.; Powles T. B.; Galsky M. D.; Cat...
ANNALS OF ONCOLOGY/36(2), 2025-09 - Bladder preservation therapy in combination with atezolizumab and radiation therapy (BPT-ART) for invasive bladder cancer: Final analysis from a multicenter, open-label, prospective phase II trial
Nagumo Y.; Kimura T.; Ishikawa H.; Sekino Y.; Maruo ...
ANNALS OF ONCOLOGY/36(2), 2025-09 - A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol
Matsumoto Takashi; Tanegashima Tokiyoshi; Takeuchi Ari...
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2025-12-01 - Clinical and histopathological features of alopecia associated with enfortumab vedotin treatment
Oya Kazumasa; Ishii Yoshiyuki; Anju Keisuke; Takano A...
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY/(41328716), 2025-12-02 - Real-World Outcomes of Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Results From the Final Analysis of Postmarketing Surveillance
Kikuchi Eiji; Nagata Masayoshi; Ito Taito; Sato Masas...
CANCER MEDICINE/14(21), 2025-10-30 - Avelumab Maintenance Therapy in Patients With Curatively Unresectable Urothelial Carcinoma in Japan: Subgroup Analyses of Post-Marketing Surveillance Data by Age, Prior Chemotherapy Regimen, and Best Overall Response to Prior Chemotherapy
Nagata Masayoshi; Kikuchi Eiji; Ito Taito; Sato Masas...
CANCER MEDICINE/14(21), 2025-10-30 - Automated EMG-Based Classification of Upper Extremity Motor Impairment Levels in Subacute Stroke
Anastasiev Alexey; Kadone Hideki; Marushima Aiki; Wata...
Sensors/25(22), 2025-11 - more...
- Durvalumab (D) in combination with Bacillus Calmette-Guerin (BCG) Induction (I) and Maintenance (M) therapy for BCG-naive, high-risk Non-Muscle-Invasive Bladder Cancer (NMIBC): Outcomes for Patients (pts) aged ≥65 years from POTOMAC